Aetna (AET) Stock Rating Lowered by Citigroup

Citigroup lowered shares of Aetna (NYSE:AET) from a buy rating to a neutral rating in a research note released on Wednesday, January 31st, Marketbeat Ratings reports. They currently have $212.00 price objective on the stock, up from their previous price objective of $187.89.

Several other research firms have also recently weighed in on AET. BMO Capital Markets boosted their price objective on Aetna from $175.00 to $200.00 and gave the stock a market perform rating in a research report on Friday, October 27th. Morgan Stanley cut Aetna from an overweight rating to an equal weight rating and set a $179.00 price objective for the company. in a research report on Wednesday, December 20th. Cantor Fitzgerald lowered Aetna from an overweight rating to a neutral rating in a research note on Thursday, October 26th. Zacks Investment Research upgraded Aetna from a hold rating to a strong-buy rating and set a $184.00 price target on the stock in a research note on Wednesday, October 25th. Finally, Credit Suisse Group restated a neutral rating and set a $195.00 price target (up from $174.00) on shares of Aetna in a research note on Wednesday, December 6th. Ten research analysts have rated the stock with a hold rating and fourteen have issued a buy rating to the company. The stock currently has a consensus rating of Buy and a consensus price target of $185.94.

Shares of Aetna (NYSE:AET) opened at $176.77 on Wednesday. The stock has a market capitalization of $57,790.00, a price-to-earnings ratio of 30.74, a P/E/G ratio of 1.44 and a beta of 0.60. Aetna has a 12-month low of $121.60 and a 12-month high of $194.40. The company has a current ratio of 1.68, a quick ratio of 0.53 and a debt-to-equity ratio of 0.52.

Aetna (NYSE:AET) last announced its quarterly earnings results on Tuesday, January 30th. The company reported $1.25 earnings per share for the quarter, topping analysts’ consensus estimates of $1.18 by $0.07. Aetna had a return on equity of 21.50% and a net margin of 3.15%. The company had revenue of $14.74 billion during the quarter, compared to analysts’ expectations of $14.79 billion. During the same quarter in the previous year, the firm earned $0.08 earnings per share. The business’s quarterly revenue was down 6.2% compared to the same quarter last year. equities analysts forecast that Aetna will post 10.99 EPS for the current year.

The business also recently declared a quarterly dividend, which was paid on Friday, January 26th. Stockholders of record on Thursday, January 11th were paid a $0.50 dividend. This represents a $2.00 dividend on an annualized basis and a dividend yield of 1.13%. The ex-dividend date was Wednesday, January 10th. Aetna’s dividend payout ratio (DPR) is currently 34.78%.

A number of institutional investors have recently modified their holdings of AET. Farallon Capital Management LLC acquired a new stake in Aetna during the 4th quarter worth $940,734,000. Janus Henderson Group PLC increased its holdings in Aetna by 9,446.2% during the 2nd quarter. Janus Henderson Group PLC now owns 4,328,900 shares of the company’s stock worth $657,255,000 after purchasing an additional 4,283,553 shares in the last quarter. Deutsche Bank AG increased its holdings in Aetna by 57.5% during the 4th quarter. Deutsche Bank AG now owns 2,704,723 shares of the company’s stock worth $487,900,000 after purchasing an additional 987,156 shares in the last quarter. Alpine Associates Management Inc. bought a new position in Aetna during the 4th quarter worth about $159,933,000. Finally, Amundi Pioneer Asset Management Inc. increased its holdings in Aetna by 1,087.9% during the 4th quarter. Amundi Pioneer Asset Management Inc. now owns 926,948 shares of the company’s stock worth $167,213,000 after purchasing an additional 848,913 shares in the last quarter. 87.10% of the stock is currently owned by institutional investors and hedge funds.

COPYRIGHT VIOLATION WARNING: “Aetna (AET) Stock Rating Lowered by Citigroup” was posted by Dispatch Tribunal and is the property of of Dispatch Tribunal. If you are reading this news story on another website, it was copied illegally and republished in violation of U.S. and international trademark & copyright legislation. The legal version of this news story can be read at https://www.dispatchtribunal.com/2018/02/15/citigroup-downgrades-aetna-aet-to-neutral.html.

About Aetna

Aetna Inc is a diversified healthcare benefits company. The Company operates through three segments: Health Care, Group Insurance and Large Case Pensions. It offers a range of traditional, voluntary and consumer-directed health insurance products and related services, including medical, pharmacy, dental, behavioral health, group life and disability plans, medical management capabilities, Medicaid healthcare management services, Medicare Advantage and Medicare Supplement plans, workers’ compensation administrative services and health information technology (HIT) products and services.

Analyst Recommendations for Aetna (NYSE:AET)

Receive News & Ratings for Aetna Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Aetna and related companies with MarketBeat.com's FREE daily email newsletter.

Leave a Reply